Value and reimbursement documents
1 min read5 pages below
This branch covers documents that present or communicate a health technology’s value for reimbursement decisions, divided by document type: assessment submissions, national and payer dossiers, economic reports and published guidance. It leaves assessment methods, economic concepts and ethics to health economics and technology assessment, collaboration with economists to working with health economists, and medicine authorisation dossiers to marketing authorisation.
- Health technology assessment submissions — the value story, global and local dossiers, agency requirements and submission preparation
- Early benefit assessment dossiers — Germany’s added-benefit assessment, dossier modules, responsibilities and timetable
- US formulary dossiers — the AMCP format, clinical and economic evidence, payer recipients and dossier development
- Health economic reports — the decision question, perspective, model, uncertainty and CHEERS reporting guidance
- Health technology guidance — an assessment body’s recommendations, drafting and editing, and information for the public